Paramethoxyethylamphetamine
From Wikipedia, the free encyclopedia
|
Paramethoxyethylamphetamine
|
|
| Systematic (IUPAC) name | |
| N-ethyl-1-(4-methoxyphenyl)propan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C12H19NO |
| Mol. mass | 193.285 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Para-methoxy-ethylamphetamine or PMEA is a stimulant drug related to PMA and ethylamphetamine.
PMEA reputedly produces similar effects to PMA, but is considerably less potent [1] and seems to have slightly less tendency to produce severe hyperthermia, at least at low doses. At higher doses however the side effects and danger of death approach those of PMA itself, and PMEA should still be considered a potentially dangerous drug.
CAS number: 93963-24-7 (hydrochloride)
[edit] References
- ^ Bustamante D, Diaz-Veliz G, Paeile C, Zapata-Torres G, Cassels BK. Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives. Pharmacology Biochemistry and Behavior. 2004 Oct;79(2):199-212.

